Journal
NANO LETTERS
Volume 8, Issue 12, Pages 4221-4228Publisher
AMER CHEMICAL SOC
DOI: 10.1021/nl801878d
Keywords
-
Categories
Funding
- National Institutes of Health MSTP [GM07739, NIH 1R21 CA 128406-01, NIH R01 CA 55399, NIH P01 CA 23766]
- Lymphoma, Glades, and Tudor Foundations
- Memorial Sloan Kettering Brain Tumor Committee
- Memorial Sloan Kettering Experimental Therapeutics Center
- NATIONAL CANCER INSTITUTE [R01CA055349, R21CA128406, P01CA023766, P01CA033049] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Single-wall carbon nanotubes (SWNT) show promise as nanoscale vehicles for targeted therapies. We have functionalized SWNT using regioselective chemistries to confer capabilities of selective targeting using RGD ligands, radiotracing using radiometal chelates, and self-assembly using oligonucleotides. The constructs contained approximately 2-7 phosphorothioate oligonucleotide chains and 50-75 amines per 100 nm length of SWNT, based on a loading of 0.01-0.05 mmol/g and 0.3-0.6 mmol/g, respectively. Dynamic light scattering suggested the functionalized SWNT were well dispersed, without formation of large aggregates in physiologic solutions. The SWNT-oligonucleotide conjugate annealed with a complementary oligonucleotide sequence had a melting temperature of 54 degrees C. Biodistribution in mice was quantified using radiolabeled SWNT-oligonucleotide conjugates. Appended RGD ligands allowed for specific binding to tumor cells in a flow cytometric assay. The techniques employed should enable the synthesis of multifunctional SWNT capable of self-assembly in biological settings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available